黄体期人绒毛膜促性腺激素支持治疗不明原因复发性妊娠丢失——低垂之果?
这项回顾性队列研究纳入98例不明原因复发性妊娠丢失(uRPL)女性,45例接受135个无HCG支持的监测周期,53例接受142个黄体中期单次注射HCG的周期。HCG组流产率降低、至妊娠时间缩短(P=0.0005),持续妊娠机会增加(RR=2.4;95%CI 1.4-3.6;NNT=7;95%CI 4-18),流产绝对风险降低(P<0.001;ARR=11.5%;95%CI 3.6-19.5;NNT=9;95%CI 5-27)。作者认为黄体期HCG支持可能改善uRPL女性结局,但需进一步随机对照试验。
要点
- 黄体中期单次HCG注射与uRPL女性流产率降低相关(ARR=11.5%;95%CI 3.6-19.5;NNT=9;95%CI 5-27)。
- HCG组持续妊娠机会增加(RR=2.4;95%CI 1.4-3.6;NNT=7;95%CI 4-18)。
- 作者认为黄体期HCG支持可能改善uRPL结局,但需进一步随机对照试验。
核心结论
- 这些数据提示恢复同步性和黄体支持可改善复发性妊娠丢失女性的结局。
- 作者认为黄体期HCG用于复发性妊娠丢失女性需进一步随机对照试验。
研究设计与样本
- 回顾性队列研究纳入98例不明原因复发性妊娠丢失女性。
- 45例接受135个无HCG支持的监测周期。
- 53例接受142个黄体中期单次注射HCG的周期。
主要发现
- 基于Log-rank Mantel-Cox生存曲线,HCG组流产率和至妊娠时间降低(P=0.0005)。
- 接受黄体期HCG支持的女性持续妊娠机会高于未接受者(RR=2.4;95%CI 1.4-3.6;NNT=7;95%CI 4-18)。
- 接受HCG支持者流产绝对风险降低(P<0.001;ARR=11.5%;95%CI 3.6-19.5;NNT=9;95%CI 5-27)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文结论提出需进一步随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recurrent pregnancy loss (RPL) is defined by two or more failed pregnancies and accounts for only 1-5% of pregnancy failures. Treatment options for unexplained RPL (uRPL) are limited. Previous studies suggest a link between delayed implantation and pregnancy loss. Based on this, a timely signal for rescue of the corpus luteum (CL) using human chorionic gonadotrophin (HCG) could improve outcomes in women with uRPL. This retrospective cohort study included 98 subjects with uRPL: 45 underwent 135 monitored cycles without HCG support; and 53 underwent 142 cycles with a single mid-luteal HCG injection. Based on Log-rank Mantel-Cox survival curves, miscarriage rate and time to pregnancy decreased in the HCG group (P = 0.0005). Women receiving luteal HCG support had an increased chance of an ongoing pregnancy compared with those not receiving it (RR = 2.4; 95% CI 1.4-3.6; number need to treat (NNT) = 7; 95% CI 4-18). Subjects receiving HCG support had a significant absolute risk reduction (ARR) of miscarriage (P < 0.001; ARR = 11.5%; 95% CI 3.6-19.5; NNT = 9(5-27). These data suggest restoration of synchrony and CL support improves outcomes in women with RPL. Further randomized controlled trials of luteal-phase HCG in women with RPL appears warranted.
引用
- Fox C, Azores-Gococo D, Swart L, et al. Luteal phase HCG support for unexplained recurrent pregnancy loss - a low hanging fruit? Reprod Biomed Online. 2016. PMID: 28041830. doi:10.1016/j.rbmo.2016.11.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。